These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 6273933)

  • 21. [Rh and ABO incompatibility].
    Brandl K
    Wien Klin Wochenschr; 1965 Oct; 77(42):814-5. PubMed ID: 4956671
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunohematology of hemolytic disease of the newborn].
    Hrubisko M
    Cesk Gynekol; 1969 Oct; 34(8):465-9. PubMed ID: 4187682
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility].
    de Sousa JS
    Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status of prevention of Rh-isoimmunization at the Obstetric and Gynecological Clinic of the University of Naples].
    Paladini A; Rascio B; Di Lieto A; Tinelli FG
    Arch Ostet Ginecol; 1970; 75(5):367-74. PubMed ID: 5003501
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of hemolytic disease of the newborn caused by maternal anti-Fyl alloimmunization].
    Agosti S; Moroni GA; Zuliani G; Meschia M
    Ann Ostet Ginecol Med Perinat; 1980; 101(1):55-9. PubMed ID: 7396333
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 27. [A clinical case of pregnancy isoimmunization caused by the Kell system].
    Orsini G; Serratì A; Schonauer S; Cramarossa D
    Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemolytic disease of the newborn caused by incompatibility between mother and child of Rh and ABO blood types].
    Ogawa T
    Kango; 1966 Jul; 18(7):31-4. PubMed ID: 4958717
    [No Abstract]   [Full Text] [Related]  

  • 30. [Simultaneous hemolytic diseases in mother and child resulting from a rare form of isoimmunization].
    Joó-Szabados T; Kun E; Hervei S
    Orv Hetil; 1977 Mar; 118(13):757-9. PubMed ID: 403497
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with a new preparation of Rh 0 (D) immune globulin (human).
    Wurzel JF; Hansen LM; Evensen KL
    Obstet Gynecol; 1973 May; 41(5):760-4. PubMed ID: 4633212
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood group incompatible pregnancy].
    Okubo M; Maeda H; Suzuki M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():727-30. PubMed ID: 16111382
    [No Abstract]   [Full Text] [Related]  

  • 35. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 36. [Unusual fetomaternal blood group antagonism].
    van Niekerk EJ; Meuwissen JH
    Ned Tijdschr Geneeskd; 1979 Mar; 123(9):323-7. PubMed ID: 105299
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical significance of free and bound Rh antibodies in Rh (c) hemolytic disease of the newborn].
    Spasova K; Vulcheva B; Purvanova Z
    Akush Ginekol (Sofiia); 1979; 18(1):17-9. PubMed ID: 107823
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of Rh isoimmunization].
    Vedra B; Smeral P
    Cesk Pediatr; 1971 Jun; 26(6):307-8. PubMed ID: 4996776
    [No Abstract]   [Full Text] [Related]  

  • 39. [ABO and Rh(D) blood groups in populations of the Lagunera region of Mexico (calculation of the incidence of single and double incompatibility between spouses and maternofetal incompatibility)].
    Garza Chapa R; Tobías Chávez R; Cerda Flores RM; Leal Garza CH
    Salud Publica Mex; 1984; 26(2):130-7. PubMed ID: 6427942
    [No Abstract]   [Full Text] [Related]  

  • 40. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.